Single domain antibodies (sdAbs) have become versatile tools in biomedical research and therapy. These antibody fragments have unique properties that make them ideal for a variety of applications. Our company utilizes GeniusAb™ mice to generate sdAbs that exhibit exceptional affinity and specificity. With these antibodies, our scientists can further develop diagnostic reagents and therapeutic drugs, thereby promoting the innovative application of sdAb in the biopharmaceutical field.